Patient handout: What is PROM?

Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.

Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.

Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.

Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.

Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.

On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.

Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.

Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.